Survival trends and prognostic factors in patients with solitary plasmacytoma of bone: A population‐based study

por Shen, Xuxing, Liu, Shu, Wu, Chao, Wang, Jing, Li, Jianyong, Chen, Lijuan
Publicado 2020

Baohuoside I Inhibits Tumor Angiogenesis in Multiple Myeloma via the Peroxisome Proliferator–Activated Receptor γ/Vascular Endothelial Growth Factor Signaling Pathway

por Chen, Ying, Zhang, Lina, Zang, Xiaoyan, Shen, Xuxing, Li, Jianyong, Chen, Lijuan
Publicado 2022

Survival trends and prognostic factors for patients with extramedullary plasmacytoma: A population-based study

por Shen, Xuxing, Zhang, Lina, Wang, Jing, Chen, Lijuan, Liu, Shu, Zhang, Run
Publicado 2022

Single-cell transcriptomic atlas throughout anti-BCMA CAR-T therapy in patients with multiple myeloma

por Xia, Yuan, Zhao, Qian, Shen, Xuxing, Jin, Yuanyuan, Wang, Jing, Zhu, Jianfeng, Chen, Lijuan
Publicado 2023

TRPV2-induced Ca(2+)-calcineurin-NFAT signaling regulates differentiation of osteoclast in multiple myeloma

por Bai, Hua, Zhu, Huayuan, Yan, Qing, Shen, Xuxing, Lu, Xiupan, Wang, Juejin, Li, Jianyong, Chen, Lijuan
Publicado 2018

Comprehensive meta-analysis of anti-BCMA chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myeloma

por Zhang, Lina, Shen, Xuxing, Yu, Wenjun, Li, Jing, Zhang, Jue, Zhang, Run, Li, Jianyong, Chen, Lijuan
Publicado 2021

Identification of clinical implications and potential prognostic models of chromatin regulator mutations in multiple myeloma

por Zhang, Lina, Zhang, Run, Wang, Jing, Chen, Ying, Qiao, Chun, Shi, Qinglin, Jin, Yuanyuan, Shen, Xuxing, Li, Jianyong, Chen, Lijuan
Publicado 2022

Anti-tumor activity of a novel proteasome inhibitor D395 against multiple myeloma and its lower cardiotoxicity compared with carfilzomib

por Shen, Xuxing, Wu, Chao, Lei, Meng, Yan, Qing, Zhang, Haoyang, Zhang, Lina, Wang, Xueyuan, Yang, Ye, Li, Jianyong, Zhu, Yongqiang, Chen, Lijuan
Publicado 2021